Menu

RNA Protects “Naked” Genomes from Retrotransposons

Transfer RNA fragments prevent jumping genes from hopping around in the mouse embryo, when histone methylation can’t do the job.

Jun 30, 2017
Shawna Williams

WIKIMEDIA, MARIUSWALTERTo protect their genes from being wrecked by retrotransposons, or jumping genes, mouse cells usually employ histone methylation to stop these rogue genetic elements from being transcribed. But how does the genome stay protected in the pre-implantation embryo, when methyl groups are temporarily stripped from cells’ DNA. A new study, published yesterday (June 29) in Cell, finds tRNA fragments are key.

Based on previous studies in fruit flies, Andrea Schorn and Rob Martienssen of Cold Spring Harbor Laboratory thought the answer to what protects vulnerable mouse embryo genomes might lie in small RNAs. To find them, they made some tweaks to the usual techniques. As they explain in their paper, “many small RNA sequencing studies omit RNA fragments shorter than 19 [nucleotides] or discard sequencing reads that map to multiple loci in the genome, thus often discarding reads matching young, potentially active transposons…” 

By including smaller fragments in their RNA library and analysis, the authors turned up “very abundant” 18- and 22-nucleotide fragments of tRNAs. Results of further experiments suggested the 18-nucleotide fragments occupy the retrotransposons’ primer binding sites, blocking full tRNA molecules from binding there and initiating replication, while the 22-nucleotide fragments post-transcriptionally silence a protein needed for retrotransposition.

See “Tethering transposons”      

“It’s plausible that this is a very ancient mechanism that cells have found to not only inhibit retrotransposons but help in protection against viruses as well,” Martienssen says in a statement.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!